大肠激躁症治疗市场规模、份额、分析报告：2025-2030 年按类型、产品、分销管道、地区和细分市场预测

Irritable Bowel Syndrome Treatment Market Size, Share & Analysis Report By Type (IBS-C, IBS-D), By Product (Xifaxan, Linzess/Constella, Viberzi, Amitiza), By Distribution Channel, By Region, And Segment Forecasts, 2025 - 2030

出版日期: 2024年10月10日 | 出版商:

Grand View Research | 英文 100 Pages | 商品交期: 2-10个工作天内

价格

简介目录图表

大肠激躁症治疗市场成长与趋势：

Grand View Research, Inc.最新报告显示，2030年全球大肠激躁症治疗市场规模预计将达到60.2亿美元，2025年至2030年复合年增长率为8.8%。

目标疾病盛行率的上升和现有药物适应症的扩大可能会加速市场成长。此外，药物的渗透和新产品的推出预计将推动大肠激躁症（IBS）治疗市场的发展。

IBS 是最常见的胃肠道疾病之一，全球盛行率通常在 10% 至 15% 之间。儘管大多数肠躁症患者年龄在 50 岁以下，但许多老年人也受到影响。症状的影响范围从轻微的不便到严重的虚弱。 IBS 可以影响患者工作、情绪和社交生活的许多方面。患有中度至重度疾病的患者通常会与经常损害他们的情感、身体、教育、社交和财务健康的症状作斗争。

症状多种多样，有时甚至是矛盾的，便秘和腹泻交替出现。长期症状会干扰患者的工作和个人活动，通常会限制个人的潜力。这些因素进一步增加了治疗大肠激躁症的需要，以便患者能够过正常的生活。

约40%的患者患有轻度IBS，35%患有中度IBS，25%患有重度IBS。许多人无法辨识肠躁症的症状，它仍然是医生诊断的最常见疾病之一。并非所有有肠躁症症状的人都会接受治疗。然而，光是在美国，每年就有 240 至 350 万人次因大肠激躁症就诊。在全球范围内，它影响了大约 35-40% 的男性和 60-65% 的女性。

大肠激躁症治疗市场报告亮点

由于 Linzes（Linaclotide）和 Amitiza（鲁比前列酮）等有效药物的普及和采用的增加，预计 IBS-C 领域在预测期内将以 11.9% 的复合年增长率增长。
由于诊断病例的增加以及对生活品质影响的更好理解，IBS-D 领域在 2024 年以 49.8% 的最大销售份额占据市场主导地位。
Lindseth/Constella 占据市场主导地位，2024 年占据最大销售份额，达到 37.3%。
医院药局引领市场，并在 2024 年占据最大的收益占有率。这是由于其全面的基础设施和综合患者照护系统。
北美大肠激躁症（IBS）治疗市场主导全球市场，2024年占最大收益占有率为37.5%。
欧洲大肠激躁症治疗市场的成长是由旨在减少胃肠道疾病耻辱感的宣传活动不断加强所推动的。在德国和英国等国家，患者对 IBS 症状和可用治疗方法的参与度正在增加。

The global irritable bowel syndrome treatment market size is expected to reach USD 6.02 billion by 2030, registering a CAGR of 8.8% from 2025 to 2030, according to a new report by Grand View Research, Inc. Rising prevalence of target disease and increasing label extension of existing drugs are likely to accelerate market growth. In addition, growing uptake of drugs and launch of novel products are anticipated to drive the irritable bowel syndrome (IBS) treatment market.

IBS is one of the most common gastrointestinal disorders, with the worldwide prevalence rate usually ranging between 10-15%. Most of the patients with IBS are under 50 years of age but many older adults suffer as well. The effect of the condition can vary from mild inconvenience to serious debilitation. It can control many facets of a patient's professional, emotional, and social life. Patients with moderate to severe conditions usually struggle with symptoms that frequently impair their emotional, physical, educational, social, and economic wellbeing.

Symptoms can vary and are sometimes contradictory, constipation can alternate with diarrhea. Long-term symptoms can disturb the patient's professional and personal activities, and usually limits an individual's potential.These factors further increase the need for irritable bowel syndrome treatment, which enable patients to go on with their regular life.

Around 40% patients have mild IBS, 35% have moderate IBS, and 25% have severe IBS. A significant number of people cannot distinguish IBS symptoms; it is still one of the most common disorders diagnosed by physicians. Not everyone with IBS symptoms pursues treatment for the same. Though, there are around 2.4-3.5 million yearly doctor visits for irritable bowel syndrome in U.S. alone. Globally, it affects around 35-40% of males and 60-65% of females.

Irritable Bowel Syndrome Treatment Market Report Highlights:

The IBS-C segment is expected to grow at a CAGR of 11.9% over the forecast period, owing to the increasing prevalence of this condition and the rising adoption of effective medications such as Linzess (linaclotide) and Amitiza (lubiprostone).
The IBS-D segment dominated the market with the largest revenue share of 49.8% in 2024 attributed to a rise in diagnosed cases and an increasing understanding of the condition's impact on quality of life.
Linzess/Constella dominated the market and accounted for the largest revenue share of 37.3% in 2024 attributed to its effectiveness in managing constipation-predominant IBS (IBS-C).
Hospital pharmacies led the market and accounted for the largest revenue share in 2024, which is attributed to their comprehensive infrastructure and integrated patient care systems.
North America irritable bowel syndrome (IBS) treatment market dominated the global market and accounted for the largest revenue share of 37.5% in 2024 attributed to the high prevalence of IBS and the increasing awareness of its management options.
The growth of Europe irritable bowel syndrome treatment market is driven by increasing awareness campaigns aimed at destigmatizing gastrointestinal disorders. Countries such as Germany and the UK are seeing increased patient engagement regarding IBS symptoms and available treatments.

Chapter 1. Methodology and Scope

1.1. Market Segmentation and Scope
1.2. Market Definitions
1.3. Research Methodology
- 1.3.1. Information Procurement
- 1.3.2. Information or Data Analysis
- 1.3.3. Market Formulation & Data Visualization
- 1.3.4. Data Validation & Publishing
1.4. Research Scope and Assumptions
- 1.4.1. List of Data Sources

Chapter 2. Executive Summary

2.1. Market Outlook
2.2. Segment Outlook
2.3. Competitive Insights

Chapter 3. Irritable Bowel Syndrome Treatment Market Variables, Trends, & Scope

3.1. Market Introduction/Lineage Outlook
3.2. Market Size and Growth Prospects (USD Million)
3.3. Market Dynamics
- 3.3.1. Market Drivers Analysis
- 3.3.2. Market Restraints Analysis
3.4. Irritable Bowel Syndrome Treatment Market Analysis Tools
- 3.4.1. Porter's Analysis
  - 3.4.1.1. Bargaining power of the suppliers
  - 3.4.1.2. Bargaining power of the buyers
  - 3.4.1.3. Threats of substitution
  - 3.4.1.4. Threats from new entrants
  - 3.4.1.5. Competitive rivalry
- 3.4.2. PESTEL Analysis
  - 3.4.2.1. Political landscape
  - 3.4.2.2. Economic and Social landscape
  - 3.4.2.3. Technological landscape
  - 3.4.2.4. Environmental landscape
  - 3.4.2.5. Legal landscape

Chapter 4. Irritable Bowel Syndrome Treatment Market: Type Estimates & Trend Analysis

4.1. Type Market Share, 2024 & 2030
4.2. Type Segment Dashboard
4.3. Market Size & Forecasts and Trend Analysis, by Type, 2018 to 2030 (USD Million)
4.4. IBS-C
- 4.4.1. IBS-C Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.5. IBS-D
- 4.5.1. IBS-D Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 5. Irritable Bowel Syndrome Treatment Market: Drug Class Estimates & Trend Analysis

5.1. Drug Class Market Share, 2024 & 2030
5.2. Drug Class Segment Dashboard
5.3. Market Size & Forecasts and Trend Analysis, by Drug Class, 2018 to 2030 (USD Million)
5.4. Xifaxan
- 5.4.1. Xifaxan Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
5.5. Linzess/Constella
- 5.5.1. Linzess/Constella Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
5.6. Viberzi
- 5.6.1. Viberzi Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
5.7. Amitiza
- 5.7.1. Amitiza Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
5.8. Others
- 5.8.1. Others Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 6. Irritable Bowel Syndrome Treatment Market: Distribution Channel Estimates & Trend Analysis

6.1. Distribution Channel Market Share, 2024 & 2030
6.2. Distribution Channel Segment Dashboard
6.3. Market Size & Forecasts and Trend Analysis, by Distribution Channel , 2018 to 2030 (USD Million)
6.4. Hospital Pharmacy
- 6.4.1. Hospital Pharmacy Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
6.5. Retail Pharmacy
- 6.5.1. Retail Pharmacy Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
6.6. Others
- 6.6.1. Others Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 7. Irritable Bowel Syndrome Treatment Market: Regional Estimates & Trend Analysis

7.1. Regional Market Share Analysis, 2024 & 2030
7.2. Regional Market Dashboard
7.3. Market Size, & Forecasts Trend Analysis, 2018 to 2030:
7.4. North America
- 7.4.1. North America Irritable Bowel Syndrome Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 7.4.2. U.S.
  - 7.4.2.1. Key Country Dynamics
  - 7.4.2.2. Regulatory Framework
  - 7.4.2.3. Competitive Insights
  - 7.4.2.4. U.S. Irritable Bowel Syndrome Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 7.4.3. Canada
  - 7.4.3.1. Key Country Dynamics
  - 7.4.3.2. Regulatory Framework
  - 7.4.3.3. Competitive Insights
  - 7.4.3.4. Canada Irritable Bowel Syndrome Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.5. Europe
- 7.5.1. Europe Irritable Bowel Syndrome Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 7.5.2. UK
  - 7.5.2.1. Key Country Dynamics
  - 7.5.2.2. Regulatory Framework
  - 7.5.2.3. Competitive Insights
  - 7.5.2.4. UK Irritable Bowel Syndrome Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 7.5.3. Germany
  - 7.5.3.1. Key Country Dynamics
  - 7.5.3.2. Regulatory Framework
  - 7.5.3.3. Competitive Insights
  - 7.5.3.4. Germany Irritable Bowel Syndrome Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 7.5.4. France
  - 7.5.4.1. Key Country Dynamics
  - 7.5.4.2. Regulatory Framework
  - 7.5.4.3. Competitive Insights
  - 7.5.4.4. France Irritable Bowel Syndrome Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 7.5.5. Italy
  - 7.5.5.1. Key Country Dynamics
  - 7.5.5.2. Regulatory Framework
  - 7.5.5.3. Competitive Insights
  - 7.5.5.4. Italy Irritable Bowel Syndrome Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 7.5.6. Spain
  - 7.5.6.1. Key Country Dynamics
  - 7.5.6.2. Regulatory Framework
  - 7.5.6.3. Competitive Insights
  - 7.5.6.4. Spain Irritable Bowel Syndrome Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.6. Asia Pacific
- 7.6.1. Asia Pacific Irritable Bowel Syndrome Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 7.6.2. China
  - 7.6.2.1. Key Country Dynamics
  - 7.6.2.2. Regulatory Framework
  - 7.6.2.3. Competitive Insights
  - 7.6.2.4. China Irritable Bowel Syndrome Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 7.6.3. Japan
  - 7.6.3.1. Key Country Dynamics
  - 7.6.3.2. Regulatory Framework
  - 7.6.3.3. Competitive Insights
  - 7.6.3.4. Japan Irritable Bowel Syndrome Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.7. Latin America
- 7.7.1. Latin America Irritable Bowel Syndrome Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 7.7.2. Brazil
  - 7.7.2.1. Key Country Dynamics
  - 7.7.2.2. Regulatory Framework
  - 7.7.2.3. Competitive Insights
  - 7.7.2.4. Brazil Irritable Bowel Syndrome Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 7.7.3. Argentina
  - 7.7.3.1. Key Country Dynamics
  - 7.7.3.2. Regulatory Framework
  - 7.7.3.3. Competitive Insights
  - 7.7.3.4. Argentina Irritable Bowel Syndrome Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.8. Middle East and Africa
- 7.8.1. Middle East and Africa Irritable Bowel Syndrome Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 7.8.2. South Africa
  - 7.8.2.1. Key Country Dynamics
  - 7.8.2.2. Regulatory Framework
  - 7.8.2.3. Competitive Insights
  - 7.8.2.4. South Africa Irritable Bowel Syndrome Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 8. Competitive Landscape

8.1. Participant Overview
8.2. Company Market Position Analysis
8.3. Company Categorization
8.4. Strategy Mapping
8.5. Company Profiles/Listing
- 8.5.1. Ironwood Pharmaceuticals, Inc.
  - 8.5.1.1. Participant's Overview
  - 8.5.1.2. Financial Performance
  - 8.5.1.3. Product Benchmarking
  - 8.5.1.4. Recent Developments/ Strategic Initiatives
- 8.5.2. Allergan
  - 8.5.2.1. Participant's Overview
  - 8.5.2.2. Financial Performance
  - 8.5.2.3. Product Benchmarking
  - 8.5.2.4. Recent Developments/ Strategic Initiatives
- 8.5.3. Astellas Pharma, Inc.
  - 8.5.3.1. Participant's Overview
  - 8.5.3.2. Financial Performance
  - 8.5.3.3. Product Benchmarking
  - 8.5.3.4. Recent Developments/ Strategic Initiatives
- 8.5.4. Takeda Pharmaceutical Company Limited
  - 8.5.4.1. Participant's Overview
  - 8.5.4.2. Financial Performance
  - 8.5.4.3. Product Benchmarking
  - 8.5.4.4. Recent Developments/ Strategic Initiatives
- 8.5.5. AstraZeneca
  - 8.5.5.1. Participant's Overview
  - 8.5.5.2. Financial Performance
  - 8.5.5.3. Product Benchmarking
  - 8.5.5.4. Recent Developments/ Strategic Initiatives
- 8.5.6. Sanofi S.A
  - 8.5.6.1. Participant's Overview
  - 8.5.6.2. Financial Performance
  - 8.5.6.3. Product Benchmarking
  - 8.5.6.4. Recent Developments/ Strategic Initiatives
- 8.5.7. Sebela Pharmaceuticals Inc
  - 8.5.7.1. Participant's Overview
  - 8.5.7.2. Financial Performance
  - 8.5.7.3. Product Benchmarking
  - 8.5.7.4. Recent Developments/ Strategic Initiatives
- 8.5.8. Bausch Health
  - 8.5.8.1. Participant's Overview
  - 8.5.8.2. Financial Performance
  - 8.5.8.3. Product Benchmarking
  - 8.5.8.4. Recent Developments/ Strategic Initiatives
- 8.5.9. Synthetic Biologics, Inc
  - 8.5.9.1. Participant's Overview
  - 8.5.9.2. Financial Performance
  - 8.5.9.3. Product Benchmarking
  - 8.5.9.4. Recent Developments/ Strategic Initiatives
- 8.5.10. Ardelyx
  - 8.5.10.1. Participant's Overview
  - 8.5.10.2. Financial Performance
  - 8.5.10.3. Product Benchmarking
  - 8.5.10.4. Recent Developments/ Strategic Initiatives

简介目录图表

List of Tables

Table 1 List of secondary sources
Table 2 List of abbreviations
Table 3 Global Irritable Bowel Syndrome Treatment Market, by Region, 2018 - 2030 (USD Million)
Table 4 Global Irritable Bowel Syndrome Treatment Market, by Type, 2018 - 2030 (USD Million)
Table 5 Global Irritable Bowel Syndrome Treatment Market, by Drug Class, 2018 - 2030 (USD Million)
Table 6 Global Irritable Bowel Syndrome Treatment Market, by Distribution Channel, 2018 - 2030 (USD Million)
Table 7 North America Irritable Bowel Syndrome Treatment Market, by Country, 2018 - 2030 (USD Million)
Table 8 North America Irritable Bowel Syndrome Treatment Market, by Type, 2018 - 2030 (USD Million)
Table 9 North America Irritable Bowel Syndrome Treatment Market, by Drug Class, 2018 - 2030 (USD Million)
Table 10 North America Irritable Bowel Syndrome Treatment Market, by Distribution Channel, 2018 - 2030 (USD Million)
Table 11 U.S. Irritable Bowel Syndrome Treatment Market, by Type, 2018 - 2030 (USD Million)
Table 12 U.S. Irritable Bowel Syndrome Treatment Market, by Drug Class, 2018 - 2030 (USD Million)
Table 13 U.S. Irritable Bowel Syndrome Treatment Market, by Distribution Channel, 2018 - 2030 (USD Million)
Table 14 Canada Irritable Bowel Syndrome Treatment Market, by Type, 2018 - 2030 (USD Million)
Table 15 Canada Irritable Bowel Syndrome Treatment Market, by Drug Class, 2018 - 2030 (USD Million)
Table 16 Canada Irritable Bowel Syndrome Treatment Market, by Distribution Channel, 2018 - 2030 (USD Million)
Table 17 Europe Irritable Bowel Syndrome Treatment Market, by Country, 2018 - 2030 (USD Million)
Table 18 Europe Irritable Bowel Syndrome Treatment Market, by Type, 2018 - 2030 (USD Million)
Table 19 Europe Irritable Bowel Syndrome Treatment Market, by Drug Class, 2018 - 2030 (USD Million)
Table 20 Europe Irritable Bowel Syndrome Treatment Market, by Distribution Channel, 2018 - 2030 (USD Million)
Table 21 UK Irritable Bowel Syndrome Treatment Market, by Type, 2018 - 2030 (USD Million)
Table 22 UK Irritable Bowel Syndrome Treatment Market, by Drug Class, 2018 - 2030 (USD Million)
Table 23 UK Irritable Bowel Syndrome Treatment Market, by Distribution Channel, 2018 - 2030 (USD Million)
Table 24 Germany Irritable Bowel Syndrome Treatment Market, by Type, 2018 - 2030 (USD Million)
Table 25 Germany Irritable Bowel Syndrome Treatment Market, by Drug Class, 2018 - 2030 (USD Million)
Table 26 Germany Irritable Bowel Syndrome Treatment Market, by Distribution Channel, 2018 - 2030 (USD Million)
Table 27 France Irritable Bowel Syndrome Treatment Market, by Type, 2018 - 2030 (USD Million)
Table 28 France Irritable Bowel Syndrome Treatment Market, by Drug Class, 2018 - 2030 (USD Million)
Table 29 France Irritable Bowel Syndrome Treatment Market, by Distribution Channel, 2018 - 2030 (USD Million)
Table 30 Italy Irritable Bowel Syndrome Treatment Market, by Type, 2018 - 2030 (USD Million)
Table 31 Italy Irritable Bowel Syndrome Treatment Market, by Drug Class, 2018 - 2030 (USD Million)
Table 32 Italy Irritable Bowel Syndrome Treatment Market, by Distribution Channel, 2018 - 2030 (USD Million)
Table 33 Spain Irritable Bowel Syndrome Treatment Market, by Type, 2018 - 2030 (USD Million)
Table 34 Spain Irritable Bowel Syndrome Treatment Market, by Drug Class, 2018 - 2030 (USD Million)
Table 35 Spain Irritable Bowel Syndrome Treatment Market, by Distribution Channel, 2018 - 2030 (USD Million)
Table 36 Asia Pacific Irritable Bowel Syndrome Treatment Market, by Country, 2018 - 2030 (USD Million)
Table 37 Asia Pacific Irritable Bowel Syndrome Treatment Market, by Type, 2018 - 2030 (USD Million)
Table 38 Asia Pacific Irritable Bowel Syndrome Treatment Market, by Drug Class, 2018 - 2030 (USD Million)
Table 39 Asia Pacific Irritable Bowel Syndrome Treatment Market, by Distribution Channel, 2018 - 2030 (USD Million)
Table 40 Japan Irritable Bowel Syndrome Treatment Market, by Type, 2018 - 2030 (USD Million)
Table 41 Japan Irritable Bowel Syndrome Treatment Market, by Drug Class, 2018 - 2030 (USD Million)
Table 42 Japan Irritable Bowel Syndrome Treatment Market, by Distribution Channel, 2018 - 2030 (USD Million)
Table 43 China Irritable Bowel Syndrome Treatment Market, by Type, 2018 - 2030 (USD Million)
Table 44 China Irritable Bowel Syndrome Treatment Market, by Drug Class, 2018 - 2030 (USD Million)
Table 45 China Irritable Bowel Syndrome Treatment Market, by Distribution Channel, 2018 - 2030 (USD Million)
Table 46 Latin America Irritable Bowel Syndrome Treatment Market, by Country, 2018 - 2030 (USD Million)
Table 47 Latin America Irritable Bowel Syndrome Treatment Market, by Type, 2018 - 2030 (USD Million)
Table 48 Latin America Irritable Bowel Syndrome Treatment Market, by Drug Class, 2018 - 2030 (USD Million)
Table 49 Latin America Irritable Bowel Syndrome Treatment Market, by Distribution Channel, 2018 - 2030 (USD Million)
Table 50 Brazil Irritable Bowel Syndrome Treatment Market, by Type, 2018 - 2030 (USD Million)
Table 51 Brazil Irritable Bowel Syndrome Treatment Market, by Drug Class, 2018 - 2030 (USD Million)
Table 52 Brazil Irritable Bowel Syndrome Treatment Market, by Distribution Channel, 2018 - 2030 (USD Million)
Table 53 Argentina Irritable Bowel Syndrome Treatment Market, by Type, 2018 - 2030 (USD Million)
Table 54 Argentina Irritable Bowel Syndrome Treatment Market, by Drug Class, 2018 - 2030 (USD Million)
Table 55 Argentina Irritable Bowel Syndrome Treatment Market, by Distribution Channel, 2018 - 2030 (USD Million)
Table 56 Middle East & Africa Irritable Bowel Syndrome Treatment Market, by Country, 2018 - 2030 (USD Million)
Table 57 Middle East & Africa Irritable Bowel Syndrome Treatment Market, by Type, 2018 - 2030 (USD Million)
Table 58 Middle East & Africa Irritable Bowel Syndrome Treatment Market, by Drug Class, 2018 - 2030 (USD Million)
Table 59 Middle East & Africa Irritable Bowel Syndrome Treatment Market, by Distribution Channel, 2018 - 2030 (USD Million)
Table 60 South Africa Irritable Bowel Syndrome Treatment Market, by Type, 2018 - 2030 (USD Million)
Table 61 South Africa Irritable Bowel Syndrome Treatment Market, by Drug Class, 2018 - 2030 (USD Million)
Table 62 South Africa Irritable Bowel Syndrome Treatment Market, by Distribution Channel, 2018 - 2030 (USD Million)

List of Figures

Fig. 1 Irritable Bowel Syndrome Treatment market segmentation
Fig. 2 Market research process
Fig. 3 Data triangulation techniques
Fig. 4 Primary research pattern
Fig. 5 Market research approaches
Fig. 6 Value-chain-based sizing & forecasting
Fig. 7 Market formulation & validation
Fig. 8 Market snapshot
Fig. 9 Segment outlook (USD Million)
Fig. 10 Competitive landscape
Fig. 11 Irritable bowel syndrome treatment market dynamics
Fig. 12 Irritable bowel syndrome treatment market: Porter's five forces analysis
Fig. 13 Irritable bowel syndrome treatment market: PESTLE analysis
Fig. 14 Irritable bowel syndrome treatment market: Type segment dashboard
Fig. 15 Irritable bowel syndrome treatment market: Type market share analysis, 2024 & 2030
Fig. 16 IBS-C market, 2018 - 2030 (USD Million)
Fig. 17 IBS-D market, 2018 - 2030 (USD Million)
Fig. 18 Irritable bowel syndrome treatment market: Drug class segment dashboard
Fig. 19 Irritable bowel syndrome treatment market: Drug class market share analysis, 2024 & 2030
Fig. 20 Xifaxan market, 2018 - 2030 (USD Million)
Fig. 21 Linzess/Constella market, 2018 - 2030 (USD Million)
Fig. 22 Viberzi market, 2018 - 2030 (USD Million)
Fig. 23 Amitiza market, 2018 - 2030 (USD Million)
Fig. 24 Others market, 2018 - 2030 (USD Million)
Fig. 25 Irritable bowel syndrome treatment market: Distribution Channel segment dashboard
Fig. 26 Irritable bowel syndrome treatment market: Distribution channel market share analysis, 2024 & 2030
Fig. 27 Hospital pharmacy market, 2018 - 2030 (USD Million)
Fig. 28 Retail pharmacy market, 2018 - 2030 (USD Million)
Fig. 29 Others market, 2018 - 2030 (USD Million)
Fig. 30 Irritable bowel syndrome treatment market revenue, by region
Fig. 31 Regional marketplace: Key takeaways
Fig. 32 North America irritable bowel syndrome treatment market, 2018 - 2030 (USD Million)
Fig. 33 U.S. country dynamics
Fig. 34 U.S. irritable bowel syndrome treatment market, 2018 - 2030 (USD Million)
Fig. 35 Canada country dynamics
Fig. 36 Canada irritable bowel syndrome treatment market, 2018 - 2030 (USD Million)
Fig. 37 Europe irritable bowel syndrome treatment market, 2018 - 2030 (USD Million)
Fig. 38 UK country dynamics
Fig. 39 UK irritable bowel syndrome treatment market, 2018 - 2030 (USD Million)
Fig. 40 Germany country dynamics
Fig. 41 Germany irritable bowel syndrome treatment market, 2018 - 2030 (USD Million)
Fig. 42 France country dynamics
Fig. 43 France irritable bowel syndrome treatment market, 2018 - 2030 (USD Million)
Fig. 44 Italy country dynamics
Fig. 45 Italy irritable bowel syndrome treatment market, 2018 - 2030 (USD Million)
Fig. 46 Spain country dynamics
Fig. 47 Spain irritable bowel syndrome treatment market, 2018 - 2030 (USD Million)
Fig. 48 Asia Pacific irritable bowel syndrome treatment market, 2018 - 2030 (USD Million)
Fig. 49 Japan country dynamics
Fig. 50 Japan irritable bowel syndrome treatment market, 2018 - 2030 (USD Million)
Fig. 51 China country dynamics
Fig. 52 China irritable bowel syndrome treatment market, 2018 - 2030 (USD Million)
Fig. 53 Latin America irritable bowel syndrome treatment market, 2018 - 2030 (USD Million)
Fig. 54 Brazil country dynamics
Fig. 55 Brazil irritable bowel syndrome treatment market, 2018 - 2030 (USD Million)
Fig. 56 Argentina country dynamics
Fig. 57 Argentina irritable bowel syndrome treatment market, 2018 - 2030 (USD Million)
Fig. 58 MEA irritable bowel syndrome treatment market, 2018 - 2030 (USD Million)
Fig. 60 South Africa country dynamics
Fig. 61 South Africa irritable bowel syndrome treatment market, 2018 - 2030 (USD Million)
Fig. 62 Company categorization
Fig. 63 Company market position analysis
Fig. 64 Strategic framework